Opalescent Appearance of an IgG1 Antibody at High Concentrations and Its Relationship to Noncovalent Association

By Sukumar Muppalla   Doyle Brandon L.   Combs Jessica L.   Pekar Allen H.  

Pharmaceutical Research, Vol. 21, Iss. 7, 2004-07 ,pp. : 1087-1093

Springer Publishing Company

Access to resources Recommend Favorite

Cetuximab: an IgG1 monoclonal antibody for the treatment of epidermal growth factor receptor-expressing tumours

By Humblet Yves  

Expert Opinion on Pharmacotherapy, Vol. 5, Iss. 7, 2004-07 ,pp. : 1621-1633

Informa Healthcare

Access to resources Recommend Favorite

Effect of pH and Excipients on Structure, Dynamics, and Long-Term Stability of a Model IgG1 Monoclonal Antibody upon Freeze-Drying

By Park Jihea   Nagapudi Karthik   Vergara Camille   Ramachander Ranjini   Laurence Jennifer   Krishnan Sampathkumar  

Pharmaceutical Research, Vol. 30, Iss. 4, 2013-04 ,pp. : 968-984

Springer Publishing Company

Access to resources Recommend Favorite

A Critical Evaluation of T_m(FTIR) Measurements of High-Concentration IgG₁ Antibody Formulations as a Formulation Development Tool

By Matheus Susanne   Mahler Hanns-Christian   Friess Wolfgang  

Pharmaceutical Research, Vol. 23, Iss. 7, 2006-07 ,pp. : 1617-1627

Springer Publishing Company

Access to resources Recommend Favorite

Conversion of TBAb Response to TSAb Response by Anti-human IgG Antibody

By  

Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders), Vol. 13, Iss. 4, 2013-12 ,pp. : 311-315

Bentham Science Publishers

Access to resources Recommend Favorite